Y. Kawaguchi et al., EUKARYOTIC ELONGATION-FACTOR-1-DELTA IS HYPERPHOSPHORYLATED BY THE PROTEIN-KINASE ENCODED BY THE U(L)13 GENE OF HERPES-SIMPLEX-VIRUS-1, Journal of virology, 72(3), 1998, pp. 1731-1736
The translation elongation factor 1 delta (EF-1 delta) consists of two
forms, a hypophosphorylated form (apparent M-r, 38,000) and a hyperph
osphorylated form (apparent M-r, 40,000). Earlier Y. Kawaguchi, R. Bru
ni, and B. Roizman (J. Virol. 71:1019-1024, 1997) reported that wherea
s mock-infected cells accumulate the hypophosphorylated form, the hype
rphosphorylated form of EF-1 delta accumulates in cells infected with
herpes simplex virus 1. We now report that the accumulation of the hyp
erphosphorylated EF-1 delta is due to phosphorylation by U(L)13 protei
n kinase based on the following observations. (i) The relative amounts
of hypo-and hyperphosphorylated EF-1 delta in Vero cells infected wit
h mutant virus lacking the U(L)13 gene could not be differentiated fro
m those of mock-infected cells. In contrast, the hyperphosphorylated E
F-1 delta was the predominant form in Vero cells infected with wild-ty
pe viruses, a recombinant virus in which the deleted U(L)13 sequences
were restored, or with a virus lacking the U(L)3 gene, which also enco
des a protein kinase. (ii) The absence of the hyperphosphorylated EF-1
delta in cells infected with the U(L)13 deletion mutant was not due t
o failure of posttranslational modification of infected-cell protein 2
2 (ICP22)/U(S)1.5 or of interaction with ICP0, inasmuch as preferentia
l accumulation of hyperphosphorylated EF-1 delta was observed in cells
infected with viruses from which the genes encoding ICP22/U(S)1.5 or
ICP0 had been deleted. (i) Both forms of EF-1 delta were labeled by P-
32(i) in vivo, but the prevalence of the hyperphosphorylated EF-1 delt
a was dependent on the presence of the U(L)13 protein. (iv) EP-1 delta
immunoprecipitated from uninfected Vero cells was phosphorylated by U
(L)13 precipitated by the anti-U(L)13 antibody from lysates of mild-ty
pe virus-infected cells, but not by complexes formed qv the interactio
n of the U(L)13 antibody with lysates of cells infected with a mutant
lacking the U(L)13 gene. This is the first evidence that a viral prote
in kinase targets a cellular protein. Together with evidence that ICPO
also interacts with EF-1 delta reported in the paper cited above, the
se data indicate that herpes simplex virus 1 has evolved a complex str
ategy for optimization of infected-cell protein synthesis.